These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 8564320)
1. A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia. Cottraux J; Note ID; Cungi C; Légeron P; Heim F; Chneiweiss L; Bernard G; Bouvard M Br J Psychiatry; 1995 Nov; 167(5):635-41. PubMed ID: 8564320 [TBL] [Abstract][Full Text] [Related]
2. Study and course of the psychological profile in 77 patients expressing panic disorder with agoraphobia after cognitive behaviour therapy with or without buspirone. Bouvard M; Mollard E; Guerin J; Cottraux J Psychother Psychosom; 1997; 66(1):27-32. PubMed ID: 8996712 [TBL] [Abstract][Full Text] [Related]
3. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia? Oei TP; Llamas M; Evans L Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805 [TBL] [Abstract][Full Text] [Related]
4. [The role of psychotherapy in managing panic disorder]. Cottraux J Encephale; 1996 Dec; 22 Spec No 5():54-60. PubMed ID: 9138948 [TBL] [Abstract][Full Text] [Related]
5. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial. Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019 [TBL] [Abstract][Full Text] [Related]
6. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444 [TBL] [Abstract][Full Text] [Related]
7. Group cognitive-behavioral treatment of panic disorder. Telch MJ; Lucas JA; Schmidt NB; Hanna HH; LaNae Jaimez T; Lucas RA Behav Res Ther; 1993 Mar; 31(3):279-87. PubMed ID: 8476402 [TBL] [Abstract][Full Text] [Related]
8. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined. Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529 [TBL] [Abstract][Full Text] [Related]
9. Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy. Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Dresler T; Notzon S; Laeger I; Arolt V; Ehlis AC; Fallgatter AJ; Zwanzger P Neuroimage Clin; 2017; 16():668-677. PubMed ID: 29085773 [TBL] [Abstract][Full Text] [Related]
10. Temporal patterns of change in panic disorder during cognitive behaviour therapy: an Indian study. Manjula M; Prasadarao PS; Kumaraiah V; Raguram R Behav Cogn Psychother; 2014 Sep; 42(5):513-25. PubMed ID: 23905590 [TBL] [Abstract][Full Text] [Related]
11. Depression, mastery and number of group sessions attended predict outcome of patients with panic and agoraphobia in a behavioural/medication program. Bowen R; South M; Fischer D; Looman T Can J Psychiatry; 1994 Jun; 39(5):283-8. PubMed ID: 8044744 [TBL] [Abstract][Full Text] [Related]
12. The impact of depressive comorbidity on neural plasticity following cognitive-behavioral therapy in panic disorder with agoraphobia. Kunas SL; Yang Y; Straube B; Kircher T; Gerlach AL; Pfleiderer B; Arolt V; Wittmann A; Stroehle A; Wittchen HU; Lueken U J Affect Disord; 2019 Feb; 245():451-460. PubMed ID: 30428445 [TBL] [Abstract][Full Text] [Related]
13. Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. Başoğlu M; Marks IM; Swinson RP; Noshirvani H; O'Sullivan G; Kuch K J Affect Disord; 1994 Feb; 30(2):123-32. PubMed ID: 7911132 [TBL] [Abstract][Full Text] [Related]
14. Baseline heartbeat perception accuracy and short-term outcome of brief cognitive-behaviour therapy for panic disorder with agoraphobia. Masdrakis VG; Legaki EM; Vaidakis N; Ploumpidis D; Soldatos CR; Papageorgiou C; Papadimitriou GN; Oulis P Behav Cogn Psychother; 2015 Jul; 43(4):426-35. PubMed ID: 24330918 [TBL] [Abstract][Full Text] [Related]
15. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Lader M; Scotto JC Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861 [TBL] [Abstract][Full Text] [Related]
16. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL. Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632 [TBL] [Abstract][Full Text] [Related]
17. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Nadiga DN; Hensley PL; Uhlenhuth EH Depress Anxiety; 2003; 17(2):58-64. PubMed ID: 12621593 [TBL] [Abstract][Full Text] [Related]
19. Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: a follow-up study. Biondi M; Picardi A Psychother Psychosom; 2003; 72(1):34-42. PubMed ID: 12466636 [TBL] [Abstract][Full Text] [Related]
20. Aerobic exercise training facilitates the effectiveness of cognitive behavioral therapy in panic disorder. Gaudlitz K; Plag J; Dimeo F; Ströhle A Depress Anxiety; 2015 Mar; 32(3):221-8. PubMed ID: 25515221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]